NeuroOne Medical Technologies Corporation Stock Analysis & AI Score
NeuroOne Medical Technologies Corporation (NMTC) has an ST Score of 42.5 (C), driven by its Forecast (A) and held back by its Profitability (D-). Analysts rate it Buy with a $5.00 price target (+275.9% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Devices |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
NeuroOne Medical Technologies Corporation (NMTC) has an ST Score of 42.5 (C), driven by its Forecast (A) and held back by its Profitability (D-). Analysts rate it Buy with a $5.00 price target (+275.9% upside).
- Strongest
- ForecastA
- Weakest
- ProfitabilityD-
All factor grades
- ForecastA
- Financial StrengthB+
- ValuationC+
- GrowthC-
- MomentumD
- ProfitabilityD-
- Piotroski3/9
Contact
NMTC stock: frequently asked questions
What is NMTC's ST Score?
NeuroOne Medical Technologies Corporation (NMTC) has an ST Score of 42.5 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is NMTC a buy, hold, or sell?
Analysts rate NMTC a Buy, with a price target of $5.00 (+275.9% vs the current price). Our ST Score grades it C (42.5/100). The ST Score is a data-driven signal, not a recommendation.
What are NMTC's factor grades?
Valuation C+, Profitability D-, Financial Strength B+, Momentum D, Growth C-, Forecast A.
What is NMTC's valuation grade?
NeuroOne Medical Technologies Corporation (NMTC) earns a valuation grade of C+, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is NMTC's growth grade?
NeuroOne Medical Technologies Corporation (NMTC) earns a growth grade of C-, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is NMTC's profitability grade?
NeuroOne Medical Technologies Corporation (NMTC) earns a profitability grade of D-, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is NMTC's financial strength grade?
NeuroOne Medical Technologies Corporation (NMTC) earns a financial strength grade of B+, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for NMTC?
The average analyst price target for NeuroOne Medical Technologies Corporation (NMTC) is $5.00 from 4 analysts, which is +275.9% versus the recent price of $1.33.
What is NMTC's Piotroski score?
NeuroOne Medical Technologies Corporation (NMTC) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.